Anti-pentraxin antibodies in autoimmune systemic diseases: Focus on anti-pentraxin-3 autoantibodies - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue International Reviews of Immunology Année : 2017

Anti-pentraxin antibodies in autoimmune systemic diseases: Focus on anti-pentraxin-3 autoantibodies

Résumé

Pentraxins are soluble pattern recognition molecules implicated not only in the opsonization and removal of microorganisms but also in the clearance of modified self (i.e., dying cells). Pentraxins can be classified into short pentraxins (C-reactive protein and serum amyloid-P component) and long pentraxins with pentraxin-3 (PTX3), the prototypic one of the latter. Pentraxins are involved in various physiological or pathophysiological processes such as inflammation and autoimmunity. A breakdown in immune tolerance to pentraxins has been reported in various autoimmune diseases. In the present review,we analyzed the current knowledge concerning anti-pentraxin antibodies,with a special focus on anti-PTX3 autoantibodies.

Domaines

Cancer
Fichier sous embargo
Fichier sous embargo
Date de visibilité indéterminée
Loading...

Dates et versions

inserm-01814831 , version 1 (13-06-2018)

Identifiants

Citer

Jean-François Augusto, Caroline Poli, Céline Beauvillain, Jean-François Subra, Sébastien Jaillon, et al.. Anti-pentraxin antibodies in autoimmune systemic diseases: Focus on anti-pentraxin-3 autoantibodies. International Reviews of Immunology, 2017, 36 (3), pp.145 - 153. ⟨10.1080/08830185.2017.1284210⟩. ⟨inserm-01814831⟩
50 Consultations
1 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More